510(k) Report

510(k) · Cleared

Cleared

Vu-Path Ultrasound System

K203657510(k) TraditionalCleared Jun 25, 2021192-day reviewClass II21 CFR 892.1550

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Crystalline Medical · IYN System, Imaging, Pulsed Doppler, Ultrasonic

Cleared on Jun 25, 2021 as substantially equivalent to K142443 (C.R. Bard, Inc., 2014) after a 192-day review. Its family tree reaches back 6 generations to 1985.

Decided
Jun 25, 2021
Review
192 days
Class
Class II
Product code
IYN
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K850478 (1985). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK850478 PLUS 1Dymax Corp · 1985
  2. 5 generations backK993624 Site-Rite 3 Ultrasound SystemDymax Corp · 1999
  3. 4 generations backK032135 Site-Rite IV Ultrasound SystemDymax Corp · 2003
  4. 3 generations backK052517 Site-Rite 5 Ultrasound SystemC.R. Bard, Inc. · 2005
  5. 2 generations backK071204 Site-Rite 6 Ultrasound System, Model Site-Rite 6C.R. Bard, Inc. · 2007
  6. 1 generation backK142443 Site-Rite 6 Ultrasound System with Pinpoint GT TechnologyC.R. Bard, Inc. · 2014
  7. This deviceK203657 Vu-Path Ultrasound SystemCrystalline Medical · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K850478PLUS 1Dymax Corp1985—
−5K993624Site-Rite 3 Ultrasound SystemDymax Corp1999—
−4K032135Site-Rite IV Ultrasound SystemDymax Corp2003—
−3K052517Site-Rite 5 Ultrasound SystemC.R. Bard, Inc.2005—
−2K071204Site-Rite 6 Ultrasound System, Model Site-Rite 6C.R. Bard, Inc.2007—
−1K142443Site-Rite 6 Ultrasound System with Pinpoint GT TechnologyC.R. Bard, Inc.2014—
0 (this device)K203657Vu-Path Ultrasound SystemCrystalline Medical2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
FIG. 1 — Lineage of K203657, 1985–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IYN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IYN device

  1. #1 K240850 EPIQ Series Diagnostic Ultrasound Systems…score 32.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K142443Site-Rite 6 Ultrasound System with Pinpoint GT Technology
Summary page 4
….1560 and 892.1570 (IYN, IYO, ITX) Classification Panel: Radiology A. Legally Marketed Predicate Devices The predicate device is the Site~Rite 6 Ultrasound System (K142443) Manufactured by C.R. Bard, Inc. B. Device Description and List Of Device Components and Accessories: The Vu-Path Ultrasound Sys…
C.R. Bard, Inc.2014—

Also cleared against K142443: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 36 years and passes through 3 companies; a new generation was cleared every 6.7 years on median.
  • None of the 7 ancestors has a recall.
  • 2 other devices also cite its predicate K142443.

How does its category compare?

All IYN devices

IYN System, Imaging, Pulsed Doppler, Ultrasonic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · IYN

57in 2025

2007: 132008: 252009: 182010: 292011: 392012: 432013: 512014: 562015: 542016: 602017: 642018: 592019: 472020: 572021: 462022: 532023: 442024: 502025: 572026 (partial year): 44
2007high 64 (2017) · low 13 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IYN

124in 2025

2007: 26 days median2008: 18 days median2009: 29 days median2010: 67 days median2011: 46 days median2012: 37 days median2013: 60 days median2014: 39 days median2015: 55 days median2016: 56 days median2017: 83 days median2018: 85 days median2019: 79 days median2020: 72 days median2021: 105 days median2022: 105 days median2023: 115 days median2024: 119 days median2025: 124 days median2026 (partial year): 107 days median
2007high 124 (2025) · low 18 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IYN

10in 2025

2007: 162008: 122009: 82010: 102011: 82012: 32013: 82014: 22015: 32016: 22018: 72020: 42021: 82022: 102023: 42024: 12025: 102026 (partial year): 2, 1 Class I
2007high 16 (2007) · low 0 (2017)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · IYN

610in 2025

2007: 32008: 22009: 92010: 172011: 182012: 202013: 182014: 482015: 1162016: 1452017: 1462018: 852019: 592020: 672021: 2132022: 1862023: 2292024: 2662025: 610
2007high 610 (2025) · low 2 (2008)2025

MAUDE reports naming product code IYN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071326163
20082518122
2009182989
201029671017
20113946818
20124337320
20135160818
20145639248
201554553116
201660562145
201764830146
20185985785
20194779059
20205772467
2021461058213
20225310510186
2023441154229
2024501191266
20255712410610
2026441072 (1)—

What is it indicated for?

The Vu-Path Ultrasound System with associated probe and accessories provide ultrasound guidance for the placement of needles and catheters in vascular structures adults aged 22 and older. Ultrasound imaging of vascular structures and surrounding tissue may also be performed. The ultrasound probe is only intended to be placed on the surface of the skin and should not be advanced percutaneously. The device provides B-Mode and Color Doppler modes of operation.

The Vu-Path Ultrasound system needle guidance technology is indicated for use by appropriately-trained healthcare professionals to provide them with visual tools for passive tracking of a needle with respect to ultrasound image data.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K203657: Vu-Path Ultrasound System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203657

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026